Trials / Completed
CompletedNCT00092690
MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)
A Multicenter, Double-Blind, Randomized, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Patients With Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,902 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This study is to assess the safety and efficacy of an investigational drug as compared to an approved drug to reduce specific cholesterol levels.
Detailed description
The duration of treatment is 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653A, ezetimibe (+) simvastatin | |
| DRUG | Comparator: atorvastatin |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2004-03-01
- Completion
- 2004-03-01
- First posted
- 2004-09-28
- Last updated
- 2024-05-10
Source: ClinicalTrials.gov record NCT00092690. Inclusion in this directory is not an endorsement.